Literature DB >> 10101689

Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction.

K M Edwards1, J E Davis, K A Browne, V R Sutton, J A Trapani.   

Abstract

Cytotoxic T cells and natural killer cells together constitute a major defence against virus infection, through their ability to induce apoptotic death in infected cells. These cytolytic lymphocytes kill their targets through two principal mechanisms, and one of these, granule exocytosis, is essential for an effective in vivo immune response against many viruses. In recent years, the authors and other investigators have identified several distinct mechanisms that can induce death in a targeted cell. In the present article, it is postulated that the reason for this redundancy of lethal mechanisms is to deal with the array of anti-apoptotic molecules elaborated by viruses to extend the life of infected cells. The fate of such a cell therefore reflects the balance of pro-apoptotic (immune) and anti-apoptotic (viral) strategies that have developed over eons of evolutionary time.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101689     DOI: 10.1046/j.1440-1711.1999.00799.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  6 in total

1.  Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis.

Authors:  A Louise McCormick; Vanessa L Smith; Dar Chow; Edward S Mocarski
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16

3.  Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.

Authors:  Boris I Chobrutskiy; Saif Zaman; Wei Lue Tong; Andrea Diviney; George Blanck
Journal:  J Neurooncol       Date:  2018-10-31       Impact factor: 4.130

4.  HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells.

Authors:  Lin Su; Ankang Hu; Yang Luo; Wenjie Zhou; Ping Zhang; Yun Feng
Journal:  Mol Cancer       Date:  2014-07-25       Impact factor: 27.401

5.  Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model.

Authors:  S Schiffer; H P Hansen; G Hehmann-Titt; M Huhn; R Fischer; S Barth; T Thepen
Journal:  Blood Cancer J       Date:  2013-03-22       Impact factor: 11.037

6.  Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma.

Authors:  Ankang Hu; Xiaoqian Dong; Xiqian Liu; Ping Zhang; Yonghong Zhang; Ning Su; Qianming Chen; Yun Feng
Journal:  Oncol Lett       Date:  2013-11-07       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.